Sdi Limited · ASX:SDI
Sdi — Investor Presentation (May 2019)
16 slides from Sdi's investor presentation, May 7, 2019
Slide 1: Investor Presentation
INVESTOR PRESENTATION Samantha Cheetham CEO May 2019
Slide 2: Your Smile. Our Vision.
YOUR SMILE. OUR VISION. Long successful operating SDI conducts research and SDI sells to 100+ countries history – founded in 1972 development of specialist on all continents, with sales and listed on ASX in 1985 dentist materials teams and warehouses in and Australia’s largest undertaking the Austra
Slide 3: Investment Summary
INVESTMENT SUMMARY • Long established business with experienced management and operational teams • Focused on an attractive niche industry serving the dental profession delivering superior gross product margins • Above market growth: 5 year CAGR of 13% in key Aesthetics and Whitening categories • Di
Slide 4: Business Summary
BUSINESS SUMMARY Core Markets Revenue by Product Sales channels Profit drivers • Europe • Worldwide distribution via • Sales growth o 35% of HY19 sales 800+ distributors and agents • Continued focus on cost • North America Amalgam 25% • Direct to dentist (in Australia control in manufacturing, 5 yea
Slide 5: Product Categories
ITS THE LITTLE THINGS THAT MAKES US SMILE PRODUCT CATEGORIES
Slide 6: Aesthetics, Whitening, Equipment, Amalgam
AESTHETICS WHITENING EQUIPMENT AMALGAM 6
Slide 7: Revenue by Category
REVENUE BY CATEGORY Aesthetics Equipment Amalgam Whitening 30 30 35 30 30 25 25 25 25 20 20 20 20 15 15 15 15 10 10 10 10 5 5 5 5 0 0 0 0 FY13 FY14 FY15 FY16 FY17 FY18 FY13 FY14 FY15 FY16 FY17 FY18 FY13 FY14 FY15 FY16 FY17 FY18 FY13 FY14 FY15 FY16 FY17 FY18 7
Slide 8: Investing for the Future
INVESTING FOR THE FUTURE • Shifting industry • Aesthetics and R&D - Intangibles trends identified Whitening 26% 25% 31% more than 20 years account for 67% Amalgam Alternative $0.3 m 43% 40% 34% ago of all sales Whitening $1.0 m 8% Equipment $1.4 m 8% • Invested heavily in • Amalgam decline Intellect
Slide 9: Financial Highlights
FINANCIAL HIGHLIGHTS §DI
Slide 10: Positive Trends
POSITIVE TRENDS EBITDA 18.0 Sales v EBITDA margin Net Debt ($m) EPS & DPS 6.4 8.0 6.4 16.0 74.1 74.1 74.5 4.7 9.3 14.0 65.3 68.7 5.5 5.2 4.7 4.8 12.0 56.6 20.8 17.3 2.1 7.0 7.3 8.5 4.0 10.0 18.0 5.3 16.3 16.4 16.9 16.2 4.9 0.0 8.0 2.6 -0.3 2.5 37.1 2.3 6.0 -1.7 2.0 6.2 6.4 1.4 2.2 5.4 5.4 4.9 4.0 4.
Slide 11: Shareholder Returns
SHAREHOLDER RETURNS $2.50 $2.25 5-year TSR: 102% $2.00 $1.75 $1.50 $1.25 $1.00 $0.75 April 2014 April 2015 April 2016 April 2017 April 2018 April 2019 Source: Iress, Market Eye
Slide 12: Strategy & Outlook
STRATEGY & OUTLOOK 12
Slide 13: Research, Innovation, Results
RESEARCH, INNOVATION, RESULTS • Two key new products to be • Very focused R+D teams launched in H2 2019 collaborating closely with researchers and innovation • Aura Easy Flowable centres globally • Zipbond adhesive • Riva star – focus on public health • 1 – 2 new products per year to programs to min
Slide 14: Strategy & Outlook
STRATEGY & OUTLOOK 4 Strategic priorities: • Brazil manufacturing trials underway with start planned 1. Rationalise product for FY20 portfolio 2. Focus on key product • In FY19, we expect continued sales growth in categories – whitening, Aesthetics and Whitening glass ionomers and products (75% of s
Slide 15: Questions
QUESTIONS 15
Slide 16: Disclaimer
DISCLAIMER THIS PRESENTATION CONTAINS SUMMARY INFORMATION ABOUT SDI LIMITED (SDI) AND ITS SUBSIDIARIES AND THEIR ACTIVITIES. THE INFORMATION IN THIS PRESENTATION DOES NOT PURPORT TO BE COMPLETE. IT SHOULD BE READ IN CONJUNCTION WITH SDI’S OTHER PERIODIC AND CONTINUOUS DISCLOSURE ANNOUNCEMENTS LODGED